Citalopram Combined with Behavioral Therapy Reduces Cocaine Use: A Double-Blind, Placebo-Controlled Trial
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Cocaine dependence continues to be a significant problem in the United States, without any approved pharmacotherapy. Promising findings from preclinical research on the effects of cocaine on serotonin lead to examination of selective serotonin reuptake inhibitors (SSRIs) as potential treatments for cocaine dependence with mixed results, possibly due to drug interactions or specifics of concomitant behavioral therapy. The purpose of this study was to examine whether the SSRI citalopram would reduce cocaine positive urines in a 12-week, double-blind placebo-controlled trial. Seventy-six cocaine dependent patients received either citalopram 20 mg per day or placebo along with cognitive behavioral therapy (CBT) and contingency management (CM). Citalopram treated subjects showed a significant reduction in cocaine-positive urines during treatment compared to placebo treated subjects. No differences were noted in retention between the two groups. Side effects reported for citalopram were mild, with none leading to discontinuation of study drug. Results of this study support further examination of citalopram in combination with behavioral therapy as a treatment for cocaine dependence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dr. Volkow and Associates Reply
VOLKOW, N. D., HITZEMANN, R., FOWLER, J. S., & WOLF, A. P. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.12.1759-b · Cited by 117
Brain maturation may be arrested in chronic cocaine addicts
Bartzokis, G., Beckson, M., Lu, P. H., Edwards, N., Bridge, P., & Mintz, J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01315-x · Cited by 85
Tenneij, N. H., van Megen, H. J. G. M., Denys, D. A. J. P., & Westenberg, H. G. M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0913 · Cited by 71 · cited 1×
“Several studies find that the addition of behavioral therapy to SSRIs improves treatment response (33, 34), and there is some evidence of a synergistic effect of behavior therapy and SSRIs in OCD treatment (35).”
Background
Cited by
From the ventral to the dorsal striatum: devolving views of their roles in drug addiction
Everitt, B. J., & Robbins, T. W. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.010 · Cited by 675
Cognitive Behavioral Therapy for Substance Use Disorders
McHugh, R. K., Hearon, B. A., & Otto, M. W. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.04.012 · Cited by 626
The role of serotonin in drug use and addiction
Müller, C. P., & Homberg, J. R. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.007 · Cited by 334
Everitt, B. J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12644 · Cited by 318
“Furthermore, stimulant abusers and their siblings tend to show obsessive-compulsive-like or ritualistic behaviours which Ersche et al. (2012b) have suggested may indicate an overlap between obsessive-compulsive disorder (OCD) and compulsive drug use in addiction, reflecting some commonality in underlying prefrontal co…”
BackgroundInfluentialA Double-Blind Randomized Controlled Trial of N -Acetylcysteine in Cannabis-Dependent Adolescents
Gray, K. M., Carpenter, M. J., Baker, N. L., DeSantis, S. M., Kryway, E., Hartwell, K. J., McRae-Clark, A. L., & Brady, K. T. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010055 · Cited by 306
Metadata
- Authors
- Moeller, F. G., Schmitz, J. M., Steinberg, J. L., Green, C. M., Reist, C., Lai, L. Y., Swann, A. C., & Grabowski, J.
- Venue
- The American Journal of Drug and Alcohol Abuse
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 33
- Issue
- 3
- Pages
- 367-378
- ISSN
- 0095-2990 (ISSN-L)
- 1097-9891
- OpenAlex
- W2063772291
- Cited by
- 103
- References
- 3
- FWCI
- 4.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.